Review Article | DOI: https://doi.org/10.31579/2640-1053/252
1ENT Head and Neck Surgery Department, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
2Pathology Department, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
*Corresponding Author: A Chebaatha., ENT Head and Neck Surgery Department, Ibn Rochd University Hospital, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
Citation: Y Oukessou., A Chebaatha., O Berrada., RL Abada., S Rouadi, et al, (2025), Primary Carcinoma of the Larynx in Females: A Case Series, J. Cancer Research and Cellular Therapeutics. 9(6); DOI:10.31579/2640-1053/252
Copyright: © 2025, A Chebaatha. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 10 November 2025 | Accepted: 24 November 2025 | Published: 28 November 2025
Keywords: larynx; laryngeal carcinoma; women; female; cancer
Background and aim: In north Africa, laryngeal carcinomas remain a pathology that predominantly the men. While in many countries the gap between men and women is narrowing. The aim of this study was to examine the epidemiological, clinical, therapeutic and follow up data of a cohort of 23 female patients treated for laryngeal carcinoma
Patients and Methods: Medical records of a cohort of 23 patients for primary carcinoma of the larynx at the Department of Head and Neck Surgery of the 20 August Hospital of Casablanca, between January 2012 and September 2016, were reviewed. Demographic, clinical, endoscopic, radiological, surgical, and follow-up data were collected.
Results: 7% of all the patient treated for LC were women, The most affected age group was between 60 and 79 years (52%), 52% had no major risk factor, all patients had an epidermoid carcinoma, 48% of patients had T2 tumors. T1, T3 and T4a were found in respectively 17%, 22% and 13%. N1 in 43% of the cases (n= 10), N0 in 35% (n=8), N2b in 17% (n= 4), N2c in 4% (n= 1). All patients were M0. All the patients of this series have undergone a surgical treatment. At 5 years, the survival rate was 83%.
Conclusion: Since the proportions of women in published studies are limited, there are still many controversies about gender differences in laryngeal cancer. Therefore, further studies should seek for a clearer understanding of factors involved in female laryngeal cancer in order to adopt in a more appropriate way the measures of prevention and early diagnosis.
Larynx carcinomas affect generally men in the fifth and sixth decades. The incidence rate of laryngeal cancer (LC) shows considerable geographical variability in both males and females [1]. In Morocco, it represents the most frequent ENT cancer that counts for 2% of all cancers, it’s the eighth common cancer in men (4.1% of all cancers). In women, LC is still rare, its incidence is estimated at 0.4% (7,7% of LC). In western countries, the gap of incidence and death between men and women has been narrowing during the past 3 decades [2] Consumption of tobacco and alcohol are the main risk factors for laryngeal cancer, along with occupational exposure to industrial carcinogenic substances. Other risk factors identified in the scientific literature, but with less conclusive evidence [3] This descriptive study aims to present results of analysis of a clinical series of 23 Moroccan female patients with cancer of larynx treated with surgery alone or a combination of surgery and postoperative chemoradiotherapy, in a Tertiary ENT referral center of Casablanca, Morocco. To date, only few papers describing this entity in the north African area are available.
All subjects or their parents were informed about the retrospective nature of the study and provided their consent prior to surgery. According to XX. We did not seek for approval of the ethics committees of the service as it is a retrospective study based on charts analysis. No human or animal experiments were involved in our study. This is a Cohort study that does not require a research registry. We performed a descriptive review based on the analysis of the medical records of a cohort of 23 patients, treated for primary carcinoma of the larynx at the Department of Head and Neck Surgery of the 20 August Hospital of Casablanca, between January 2012 and September 2016. Demographic, clinical, endoscopic, radiological, surgical, and follow-up data were collected from clinical case notes. All the patients systematically underwent a direct laryngoscopy under general anesthesia with biopsy, in order to confirm the histological nature of the lesion and to perform a loco-regional extension assessment, as well as an injected body CT scan. This allowed, in all patients, to specify the TNM classification of the tumor according to the 2017 UICC. The therapeutic decision was taken in a Multidisciplinary Consultation Meeting for all the patients. We excluded from the study the patients who refused any treatment as well as all the incomplete files, patients having histological types others than carcinomas or cancers of adjacent structures invading the larynx.
Intervention And Considerations
Therapeutic decisions were made during a multidisciplinary consultation meeting for all patients. The postoperative follow-up was assured on short- and long term, looking for any sign of recurrence. The qualitative variables were analyzed in frequency and percentage, while the quantitative variables were analyzed in medians
Between January 2012 and September 2016, 328 patients with larynx carcinoma were operated at the ENT/head and Neck surgery department of the Ibn Rochd university hospital, Casablanca, Morocco ENT Head & Neck surgery. 7% of the patients were female (n=23). The median age was 64 years (range 47–79 years). The most affected age group was between 60 and 79 years, it represented 52% of all patients [Figure 1]

Figure 1: age distribution.
In our series, 21 patients (91%) benefited from a family environment, whereas two patients were socially isolated (9%). Ten of the patients (43%) were smokers (Fig3). Three of them were passive and the other seven active smokers (30%) with an average consumption of 18.5 pack-years. Yellow industrial tobacco was the main mode of consumption. Alcohol use was found in 7 people (30%), all of them were active smokers [Figure 2].

Figure 2: smoking and alcohol consumption data.
19 patients (82%) had poor oral health with numerous untreated dental caries. GERD symptoms were present in five patients (22%). The notion of exposure to wood oven smoke was found in five patients (22%), all from rural areas. Exposure to other chemicals (cements, asbestos, chromium, nickel) incriminated in laryngeal oncogenesis was not specified in the files. All of our patients were housewives and were all of low socioeconomic status. No patient had a history of cervical irradiation nor family history of laryngeal cancer. Mean lag time between onset of symptoms and first consultation was 11 months (6 months – 5 years) [Figure 3].

Figure 3: lag time between onset of symptoms and first consultation.
Dysphonia was the leading revealing symptom (78%, n=18), that associated during the course to dyspnea in 43% of cases. Dysphagia was seen in only 2 cases (8%). Cervical swelling was found in one case (4%). Three patients (13%) experienced a deterioration of general condition [Figure 4].

Figure 4: Distribution of patients according to symptoms of discovery.
All the patients underwent a clinical examination, a CT scan and a laryngoscopy under general anesthesia with biopsy. The epidermoid carcinoma was well, moderately and poorly differentiated in respectively 78% (n=18), 13% (n=3) and 11% (n=2) 18. No Patient had a synchronous cancer. The tumor localizations were as follows: glottic in 17% (n= 4), supra-glottic in 13% (n= 3), Glotto-supraglottic in 30% (n= 7), Glotto-infraglottic in 17% (n= 4), and Glottic, supra and infraglottic in 22% (n= 5). According to the UICC 2017 classification, 48% of patients had T2 tumors. T1, T3 and T4a were found in respectively 17%, 22% and 13%. No patient had a T4b stage [Tab1]. The Lymph node assessment showed N1 in 43% of the cases (n= 10), N0 in 35% (n=8), N2b in 17% (n= 4), N2c in 4% (n= 1). No patient presented a N2a or N3 cervical lymph node metastasis [Tab2]. All patients were M0. Table 3 summarizes the distribution of patients according to tumor’s stage [Table 3].
| Classification | Pourcentage |
| T1 | 17 % |
| T2 | 48 % |
| T3 | 22 % |
| T4 | T4a : 13 ; T4b : 0% |
Table 1: T Classification according to UICC 2017.
| Classification | Pourcentage |
| N0 | 35% |
| N1 | 43% |
| N2 | N2a : 0% ; N2b :17% ; N2c :4 % |
| N3 | 0% |
Table 2: N Classification according to UICC 2017.
| Stages | Pourcentage/Numbers of patients |
Stage I T1N0M0 Stage II T2N0M0 Stage III T2N1M0 T3N1M0 Stage IV T2N2cM0 T3N2bM0 T4N0M0 T4N1M0 | 17% - n=4 n=4 8% - n=2 n=2 39% - n=9 n=8 n=1 35% - n=8 n=1 n=4 n=2 n=1 |
Table 3: distribution of patients according to tumor stage.
All the patients of this series have undergone a surgical treatment. 17% of patients (n=4, T1) were treated with an endoscopic laser cordectomy. 35% (n=8, T3 and T4) with a total laryngectomy associated to a post-operative radiotherapy. 48% (n=11, T2) with a supra-cricoid laryngectomy. Bilateral levels II to IV neck dissection were performed for T2 tumors and above. Excision limits were safe except for 1 case of supracricoid laryngectomy that needed a totalization (4%). The mean duration of hospital stay was 8.42 days (5-14). 2 patients presented a wound site infection after total laryngectomy complicated with pharyngocutaneous fistula that has been successfully managed with local care and antibiotherapy. These complications didn’t lead to any delay in postoperative radiotherapy. No major complications were noted. At 12 months follow-up, 2 patients initially treated with supracricoid laryngectomy had presented a local recurrence. A totalization was performed for one, and a radiochemotherapy for the other. At 5 years, the survival rate was 83%. All the patients have beneficiated from vocal and swallowing rehabilitation.
Squamous cell carcinomas (SCC) of the larynx are the most common malignancies of the upper aerodigestive tract in the Western hemisphere. They occur with an incidence of about 5 to 7 cases per 100,000 individuals each year, mainly affecting men between the ages of 55 and 65 years. The male-to-female ratio has been determined to range between 20 to 1 [6] and 32 to 1. [4] Larynx cancer is among the neoplasms with greatest gender differences found in most populations worldwide [5]; In Morocco, the 2008-2012 Cancer registry of Grand Casablanca reported an 0.4 per 100,000 person-years incidence of laryngeal cancer in females among Moroccan population versus 4.6 for men. This large gap in incidence according to gender is very likely to be due to the difference in levels of tobacco and alcohol exposure. In 2017, the incidence of smoking was 74.75 times higher among men that women, whereas alcohol consumption was as low as 0.4% for women vs 7.1% for men [6]. Since the LC incidence stayed stable, the trend of gap narrowing incidence and mortality of LC between men and woman, as reported in many western countries (such as USA, England and Wales) [7] has not been observed in Morocco nor in neighboring countries [8]. In this series, 57% of patients have never smoked or consumed alcohol. These findings might indicate that laryngeal cancer in our context is probably linked to factors other than smoking or alcoholism. The large male to female ratio has led to the suggestions that they might be other factors influencing the development of laryngeal carcinoma such as hormonal influences, genetic predisposition and others The larynx has been considered as a secondary sex organ that undergoes developmental and physiologic changes during puberty and throughout the menstrual cycle, combined with the high rate of laryngeal carcinomas in men, has led to the suggestion that laryngeal carcinoma might be a sex hormone-dependent tumor similar to prostate and mammary carcinoma [4].Chaudhri et al. found that there is compelling evidence that laryngeal cancer is hormone responsive, specifically to the effects of E2, via ERα36. This membrane receptor activates several pathways, which were found both in vitro and in vivo, to correlate with laryngeal cancer progression and aggressiveness [9]. However, Hagedorn et al. strongly argue against laryngeal carcinoma being sex-hormone-dependent tumors because they couldn’t find any significant amount of male and female sex-hormone receptors in an immunomorphological and biochemical study on both in-vivo and in-vitro tumor cells [4]. HPV infection, especially infection due to the high-risk type HPV-16, was found to be significantly associated with the risk of laryngeal squamous cell carcinoma [10]. It may have a synergistic effect with tobacco use, the viral cell replication may amplify the mutagenesis and metaplasia caused by smoking [11]. GERD and poor oral health are also biologically plausible risk factors for laryngopharyngeal cancers that were respectively present in 22% and 82% of the patients [12-13]. In some series analyzing gender differences in LC, it was reported that women presented with a higher degree of supraglottic involvement, whereas men predominantly presented with glottic carcinomas [14]. The reason for this difference in subsite involvement is not clear yet. As patterns of tobacco smoking and alcohol consumption change over time, say, with a decline in the proportion of male smokers and a rise in female smokers, we might expect to see both the incidence rate ratio, and the distribution of anatomical subsites equalize [7]. In our series of female patients, the glottis was more frequently involved than the supra-glottis. Gender differences in prognosis are debatable, according to some authors, female patients with laryngeal carcinoma have a better chance of survival than males, especially when the initial tumors are diagnosed in the early stages. For others, no difference was found [15-16] Kokoska et al. reported in a multivariable analysis that the 5-years survival rate for women was linked to age, comorbidity and severity of symptoms, while it was linked to age, comorbidity and anatomic subsite [17] Treatment of laryngeal cancer in women is the same as in males. After total laryngectomy (TL), alaryngeal speech is very challenging for the speaker, which can result in a high degree of voice handicap. For example, an acoustic analysis by Kazi et al. found that gender frequency differences are lost following TL for tracheoesophageal speakers. Furthermore, alaryngeal voice affected the confidence of women more than men and suffer from more concerns related to body image [18] Such concerns also may be quite applicable to those who receive less radical (conservative) treatment methods. That is, in some instances, partial laryngectomy may result in relatively greater levels of disability for a female as opposed to a male patient (e.g., a "rough'" voice quality may garner more social penalty in a woman) [19] Katz et al. have studied psychosocial impact after head and neck cancer surgical treatment, they demonstrated that women seemed to be more vulnerable, with higher levels of depression and lower life happiness; their adjustment was more closely linked to their social environment. [20].
Since the proportions of women in published studies are limited, there are still many controversies about gender differences in laryngeal cancer. Therefore, further studies should seek for a clearer understanding of etiopathogenic factors involved in female laryngeal cancer, especially in those without any significant smoking or alcohol exposure. There should also be an increased awareness among medical practitioners and the general population that laryngeal carcinoma is not a disease affecting exclusively heavy smokers and drinkers. Many studies emphasize that its impact seems to be higher for female patients as opposed to males, hence the importance of prevention and early detection.
Declaration of Competing Interest
The authors declare that they have no competing interests.
Sources of funding
This research did not receive any specific grant(s) from funding agencies in the public, commercial, on non-for-profit sectors.
Ethical approval
I certify that this kind of manuscript does not require ethical approval by the Ethical Committee of our institution.
Consent
Written informed consent was obtained from the patient for publication of this cohort study and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.
Author contribution
XX: writing the paper, study concept
XX: Corresponding author
XX: acquisition of data
XX: revising the article.
XX: revising the article.
XX: revising the article.
XX: final approval of the version to be submitted
XX: study concept
XX: study concept
Registration of research studies
This is a Case report that does not require a research registry.
Guarantor
XX
Provenance and peer review
Not commissioned, externally peer-reviewed.
Dear Editorial Team, Clinical Medical Reviews and Reports. My experience with the journal was highly positive. The peer-review process was rigorous, constructive, and completed in a timely manner. The reviewers provided valuable comments that helped improve the quality and clarity of our manuscript. The editorial office was professional, responsive, and supportive throughout all stages of the publication process. Communication was clear and efficient, and any questions were addressed promptly. Overall, I found the journal to maintain high scientific standards and an excellent publication workflow. I would be pleased to consider submitting future work to this journal. Best wishes from, Elena Popa.
It was my pleasure to submit my testimonial concerning the Reviewer Board of our Scientific Journal “Brain and Neurological Disorders”. The Reviewers focused on some modifications and their contribution was helpful. The ladies of our Editorial Office were also supported my efforts. It was my honor to have such a co-operation and I am looking forward for more collaboration.
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Thank you for the speedy and efficient peer review process. I appreciate the fact that your peer reviewers do not take months to respond like with some other journals. I would also like to thank the editorial office for responding quickly to my questions. It is an excellent journal. I plan to submit more manuscripts in the future. Best wishes from, Robert W. McGee
Dear Grace Pierce, Editorial Coordinator of Journal of Clinical Research and Reports, Working with you and your team on our recent publication in JCRR has been a truly wonderful and enjoyable experience. The responses were prompt, and the reviewers were patient, constructive, and highly professional. One reviewer in particular gave me the feeling that a professor was carefully reading and commenting on my coursework, which was deeply touching. The entire process was straightforward and hassle‑free, with no tedious online forms to complete. I highly recommend this journal. Best wishes from, DR Aibing Rao, Head of R&D
I Appreciate the Opportunity to Share my Experience with the Journal of Clinical Research and Reports. The peer review process was timely and constructive, and the feedback provided helped improve the quality of our manuscript. The editorial office was professional, responsive, and supportive throughout the process, ensuring smooth communication and efficient handling of the submission. Overall, it was a positive experience collaborating with your team.
Dear Mercy Grace, Editorial Coordinator of Obstetrics Gynecology and Reproductive Sciences, We would like to express our gratitude for your help at all stages of publishing and editing the article. The editors of the magazine answer all the necessary questions and help at every stage. We will definitely continue to cooperate and publish other works in the Obstetrics Gynecology and Reproductive Sciences! Best wishes from, Alla Konstantinovna Politova,